» Articles » PMID: 19639291

Adenosine Receptors and the Kidney

Overview
Specialty Pharmacology
Date 2009 Jul 30
PMID 19639291
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

The autacoid, adenosine, is present in the normoxic kidney and generated in the cytosol as well as at extracellular sites. The rate of adenosine formation is enhanced when the rate of ATP hydrolysis prevails over the rate of ATP synthesis during increased tubular transport work or during oxygen deficiency. Extracellular adenosine acts on adenosine receptor subtypes (A(1), A(2A), A(2B), and A(3)) in the cell membranes to affect vascular and tubular functions. Adenosine lowers glomerular filtration rate by constricting afferent arterioles, especially in superficial nephrons, and thus lowers the salt load and transport work of the kidney consistent with the concept of metabolic control of organ function. In contrast, it leads to vasodilation in the deep cortex and the semihypoxic medulla, and exerts differential effects on NaCl transport along the tubular and collecting duct system. These vascular and tubular effects point to a prominent role of adenosine and its receptors in the intrarenal metabolic regulation of kidney function, and, together with its role in inflammatory processes, form the basis for potential therapeutic approaches in radiocontrast media-induced acute renal failure, ischemia reperfusion injury, and in patients with cardiorenal failure.

Citing Articles

Sex Dependence in Control of Renal Haemodynamics and Excretion in Streptozotocin Diabetic Rats-Role of Adenosine System and Nitric Oxide.

Kuczeriszka M, Dobrowolski L Int J Mol Sci. 2024; 25(14).

PMID: 39062939 PMC: 11276843. DOI: 10.3390/ijms25147699.


Incretin and glucagon receptor polypharmacology in chronic kidney disease.

McFarlin B, Duffin K, Konkar A Am J Physiol Endocrinol Metab. 2024; 326(6):E747-E766.

PMID: 38477666 PMC: 11551006. DOI: 10.1152/ajpendo.00374.2023.


Population Pharmacokinetics of Caffeine in Neonates with Congenital Heart Disease and Associations with Acute Kidney Injury.

Thompson E, Zimmerman K, Gonzalez D, Foote H, Park S, Hill K J Clin Pharmacol. 2023; 64(3):300-311.

PMID: 37933788 PMC: 10898646. DOI: 10.1002/jcph.2382.


Role and mechanisms of SGLT-2 inhibitors in the treatment of diabetic kidney disease.

Dai Z, Chen J, Zou R, Liang X, Tang J, Yao C Front Immunol. 2023; 14:1213473.

PMID: 37809091 PMC: 10552262. DOI: 10.3389/fimmu.2023.1213473.


Nonselective and A2a-Selective Inhibition of Adenosine Receptors Modulates Renal Perfusion and Excretion Depending on the Duration of Streptozotocin-Induced Diabetes in Rats.

Sitek J, Kuczeriszka M, Walkowska A, Kompanowska-Jezierska E, Dobrowolski L Pharmaceuticals (Basel). 2023; 16(5).

PMID: 37242515 PMC: 10222446. DOI: 10.3390/ph16050732.


References
1.
Rieg T, Steigele H, Schnermann J, Richter K, Osswald H, Vallon V . Requirement of intact adenosine A1 receptors for the diuretic and natriuretic action of the methylxanthines theophylline and caffeine. J Pharmacol Exp Ther. 2004; 313(1):403-9. DOI: 10.1124/jpet.104.080432. View

2.
Miyamoto M, Yagil Y, Larson T, Robertson C, Jamison R . Effects of intrarenal adenosine on renal function and medullary blood flow in the rat. Am J Physiol. 1988; 255(6 Pt 2):F1230-4. DOI: 10.1152/ajprenal.1988.255.6.F1230. View

3.
Kellett R, Bowmer C, Collis M, Yates M . Amelioration of glycerol-induced acute renal failure in the rat with 8-cyclopentyl-1,3-dipropylxanthine. Br J Pharmacol. 1989; 98(3):1066-74. PMC: 1854752. DOI: 10.1111/j.1476-5381.1989.tb14639.x. View

4.
Weaver D, Reppert S . Adenosine receptor gene expression in rat kidney. Am J Physiol. 1992; 263(6 Pt 2):F991-5. DOI: 10.1152/ajprenal.1992.263.6.F991. View

5.
Katholi R, Taylor G, MCCANN W, Woods Jr W, Womack K, McCoy C . Nephrotoxicity from contrast media: attenuation with theophylline. Radiology. 1995; 195(1):17-22. DOI: 10.1148/radiology.195.1.7892462. View